chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 79.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abnormal behaviour, Anuria, Atelectasis, Blood glucose decreased, Blood lactic acid increased
Clinical narrative: Notes received from Medical Center. Patient was recently discharged from the hospital to a skilled living facility brought into ED because of hypoglycemia.  Per EMS, the patient's roommate at the facility noticed that the patient was not acting right.  Per note the staff at the skilled living facility checked the patient's blood sugar and it was low.  They called EMS and on EMS arrival blood sugar was 27.  EMS gave D10.  At that time patient was minimally responsive but woke up very quickly according to EMS. EMS did note patient to have transient hypotension and hypoxia.  Per report the patient denied any fever, vomiting, diarrhea, pain. Patient had dialysis and stated she does not make urine. CT of chest noted bibasilar atelectasis without other focal consolidation and shows not frank infiltrate, shows evidence of fibrosis and edema. Per Note the patient met the criteria for sepsis. PCR positive for COVID 19:  New leukocytosis with elevated LFT's and pro calcitonin and lactate. Cr shows mixed interstitial opacities. Patient was not hypoxic during exam. But received a dose of dexamethasone in ED. Received a dose of vancomycin and cefepime in ED. Labs were ordered to trend. Note stated inflammatory markers were elevated mostly from COVID. Patient was admitted to the medical floor. Patient denied any complains and stated she was feeling better. Per 2nd note, the patient's lactic acid was high due to persistent hypoglycemia, chronic renal failure, and hypoxemia.  Due to renal failure, the patient was not a great candidate to receive IV fluids. The patient was given gentle fluids. Patient was also given multiple doses of amp of dextrose 50. Per note, the patient went into respiratory failure and patient and family declined any heroic efforts or intubation. Note stated Patient was a DNR and Do not intubate. Per note, patient died comfortable on 7/31/2022 at 22:37. Health Department does not have any further information on this patient.
Age: 79.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Chronic kidney disease, Computerised tomogram thorax abnormal, Death, Dialysis
Clinical narrative: Notes received from Medical Center. Patient was recently discharged from the hospital to a skilled living facility brought into ED because of hypoglycemia.  Per EMS, the patient's roommate at the facility noticed that the patient was not acting right.  Per note the staff at the skilled living facility checked the patient's blood sugar and it was low.  They called EMS and on EMS arrival blood sugar was 27.  EMS gave D10.  At that time patient was minimally responsive but woke up very quickly according to EMS. EMS did note patient to have transient hypotension and hypoxia.  Per report the patient denied any fever, vomiting, diarrhea, pain. Patient had dialysis and stated she does not make urine. CT of chest noted bibasilar atelectasis without other focal consolidation and shows not frank infiltrate, shows evidence of fibrosis and edema. Per Note the patient met the criteria for sepsis. PCR positive for COVID 19:  New leukocytosis with elevated LFT's and pro calcitonin and lactate. Cr shows mixed interstitial opacities. Patient was not hypoxic during exam. But received a dose of dexamethasone in ED. Received a dose of vancomycin and cefepime in ED. Labs were ordered to trend. Note stated inflammatory markers were elevated mostly from COVID. Patient was admitted to the medical floor. Patient denied any complains and stated she was feeling better. Per 2nd note, the patient's lactic acid was high due to persistent hypoglycemia, chronic renal failure, and hypoxemia.  Due to renal failure, the patient was not a great candidate to receive IV fluids. The patient was given gentle fluids. Patient was also given multiple doses of amp of dextrose 50. Per note, the patient went into respiratory failure and patient and family declined any heroic efforts or intubation. Note stated Patient was a DNR and Do not intubate. Per note, patient died comfortable on 7/31/2022 at 22:37. Health Department does not have any further information on this patient.
Age: 79.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fibrosis, Hypoglycaemia, Hyporesponsive to stimuli, Hypotension, Hypoxia
Clinical narrative: Notes received from Medical Center. Patient was recently discharged from the hospital to a skilled living facility brought into ED because of hypoglycemia.  Per EMS, the patient's roommate at the facility noticed that the patient was not acting right.  Per note the staff at the skilled living facility checked the patient's blood sugar and it was low.  They called EMS and on EMS arrival blood sugar was 27.  EMS gave D10.  At that time patient was minimally responsive but woke up very quickly according to EMS. EMS did note patient to have transient hypotension and hypoxia.  Per report the patient denied any fever, vomiting, diarrhea, pain. Patient had dialysis and stated she does not make urine. CT of chest noted bibasilar atelectasis without other focal consolidation and shows not frank infiltrate, shows evidence of fibrosis and edema. Per Note the patient met the criteria for sepsis. PCR positive for COVID 19:  New leukocytosis with elevated LFT's and pro calcitonin and lactate. Cr shows mixed interstitial opacities. Patient was not hypoxic during exam. But received a dose of dexamethasone in ED. Received a dose of vancomycin and cefepime in ED. Labs were ordered to trend. Note stated inflammatory markers were elevated mostly from COVID. Patient was admitted to the medical floor. Patient denied any complains and stated she was feeling better. Per 2nd note, the patient's lactic acid was high due to persistent hypoglycemia, chronic renal failure, and hypoxemia.  Due to renal failure, the patient was not a great candidate to receive IV fluids. The patient was given gentle fluids. Patient was also given multiple doses of amp of dextrose 50. Per note, the patient went into respiratory failure and patient and family declined any heroic efforts or intubation. Note stated Patient was a DNR and Do not intubate. Per note, patient died comfortable on 7/31/2022 at 22:37. Health Department does not have any further information on this patient.
Age: 79.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Inflammatory marker increased, Laboratory test abnormal, Leukocytosis, Liver function test increased, Lung consolidation
Clinical narrative: Notes received from Medical Center. Patient was recently discharged from the hospital to a skilled living facility brought into ED because of hypoglycemia.  Per EMS, the patient's roommate at the facility noticed that the patient was not acting right.  Per note the staff at the skilled living facility checked the patient's blood sugar and it was low.  They called EMS and on EMS arrival blood sugar was 27.  EMS gave D10.  At that time patient was minimally responsive but woke up very quickly according to EMS. EMS did note patient to have transient hypotension and hypoxia.  Per report the patient denied any fever, vomiting, diarrhea, pain. Patient had dialysis and stated she does not make urine. CT of chest noted bibasilar atelectasis without other focal consolidation and shows not frank infiltrate, shows evidence of fibrosis and edema. Per Note the patient met the criteria for sepsis. PCR positive for COVID 19:  New leukocytosis with elevated LFT's and pro calcitonin and lactate. Cr shows mixed interstitial opacities. Patient was not hypoxic during exam. But received a dose of dexamethasone in ED. Received a dose of vancomycin and cefepime in ED. Labs were ordered to trend. Note stated inflammatory markers were elevated mostly from COVID. Patient was admitted to the medical floor. Patient denied any complains and stated she was feeling better. Per 2nd note, the patient's lactic acid was high due to persistent hypoglycemia, chronic renal failure, and hypoxemia.  Due to renal failure, the patient was not a great candidate to receive IV fluids. The patient was given gentle fluids. Patient was also given multiple doses of amp of dextrose 50. Per note, the patient went into respiratory failure and patient and family declined any heroic efforts or intubation. Note stated Patient was a DNR and Do not intubate. Per note, patient died comfortable on 7/31/2022 at 22:37. Health Department does not have any further information on this patient.
Age: 79.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lung opacity, Oedema, Procalcitonin increased, Respiratory failure, SARS-CoV-2 test positive
Clinical narrative: Notes received from Medical Center. Patient was recently discharged from the hospital to a skilled living facility brought into ED because of hypoglycemia.  Per EMS, the patient's roommate at the facility noticed that the patient was not acting right.  Per note the staff at the skilled living facility checked the patient's blood sugar and it was low.  They called EMS and on EMS arrival blood sugar was 27.  EMS gave D10.  At that time patient was minimally responsive but woke up very quickly according to EMS. EMS did note patient to have transient hypotension and hypoxia.  Per report the patient denied any fever, vomiting, diarrhea, pain. Patient had dialysis and stated she does not make urine. CT of chest noted bibasilar atelectasis without other focal consolidation and shows not frank infiltrate, shows evidence of fibrosis and edema. Per Note the patient met the criteria for sepsis. PCR positive for COVID 19:  New leukocytosis with elevated LFT's and pro calcitonin and lactate. Cr shows mixed interstitial opacities. Patient was not hypoxic during exam. But received a dose of dexamethasone in ED. Received a dose of vancomycin and cefepime in ED. Labs were ordered to trend. Note stated inflammatory markers were elevated mostly from COVID. Patient was admitted to the medical floor. Patient denied any complains and stated she was feeling better. Per 2nd note, the patient's lactic acid was high due to persistent hypoglycemia, chronic renal failure, and hypoxemia.  Due to renal failure, the patient was not a great candidate to receive IV fluids. The patient was given gentle fluids. Patient was also given multiple doses of amp of dextrose 50. Per note, the patient went into respiratory failure and patient and family declined any heroic efforts or intubation. Note stated Patient was a DNR and Do not intubate. Per note, patient died comfortable on 7/31/2022 at 22:37. Health Department does not have any further information on this patient.
Age: 79.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Sepsis
Clinical narrative: Notes received from Medical Center. Patient was recently discharged from the hospital to a skilled living facility brought into ED because of hypoglycemia.  Per EMS, the patient's roommate at the facility noticed that the patient was not acting right.  Per note the staff at the skilled living facility checked the patient's blood sugar and it was low.  They called EMS and on EMS arrival blood sugar was 27.  EMS gave D10.  At that time patient was minimally responsive but woke up very quickly according to EMS. EMS did note patient to have transient hypotension and hypoxia.  Per report the patient denied any fever, vomiting, diarrhea, pain. Patient had dialysis and stated she does not make urine. CT of chest noted bibasilar atelectasis without other focal consolidation and shows not frank infiltrate, shows evidence of fibrosis and edema. Per Note the patient met the criteria for sepsis. PCR positive for COVID 19:  New leukocytosis with elevated LFT's and pro calcitonin and lactate. Cr shows mixed interstitial opacities. Patient was not hypoxic during exam. But received a dose of dexamethasone in ED. Received a dose of vancomycin and cefepime in ED. Labs were ordered to trend. Note stated inflammatory markers were elevated mostly from COVID. Patient was admitted to the medical floor. Patient denied any complains and stated she was feeling better. Per 2nd note, the patient's lactic acid was high due to persistent hypoglycemia, chronic renal failure, and hypoxemia.  Due to renal failure, the patient was not a great candidate to receive IV fluids. The patient was given gentle fluids. Patient was also given multiple doses of amp of dextrose 50. Per note, the patient went into respiratory failure and patient and family declined any heroic efforts or intubation. Note stated Patient was a DNR and Do not intubate. Per note, patient died comfortable on 7/31/2022 at 22:37. Health Department does not have any further information on this patient.
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Error: Improper storage (ex. temperature/location).
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Error: Improper Storage (ex. temp./location)-
Age: 25.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Body temperature increased, Injection site erythema, Injection site induration, Injection site pain, Injection site pruritus
Clinical narrative: Patient with pain, redness, induration 3-5 cm, warmth, elevated body temperature, and itching at site of injection > 8 days
Age: 25.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Injection site warmth
Clinical narrative: Patient with pain, redness, induration 3-5 cm, warmth, elevated body temperature, and itching at site of injection > 8 days
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Hypoaesthesia, Pruritus
Clinical narrative: Burning, itchy, and Numbness of Left Thigh in a circle Appx 6 X 6
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Pyrexia, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough COVID infection. Tested due to fever on 08/07/2022. Test collected 08/07/2022 and positive.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia
Clinical narrative: Loss of taste and smell.
Age: 7.0
Sex: F
Vaccine: DTAPIPV, VARCEL
Symptoms: Decreased appetite, Night sweats, Pain, Pyrexia, Sleep terror
Clinical narrative: Extreme soreness, fever, lack of appetite, night sweats, night terrors,
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Blood gases, COVID-19, Chest tube insertion, Death, Drainage
Clinical narrative: Patient brought to Hospital via EMS on 02/17/2022 for SOB.  CT of thorax showed large right effusion, lung metastasis, bone metastasis, supraclavicular and left axillary lymphadenopathy.  Patient had a known hx of Prostate cancer, Parkinson's, dementia, and Peg Tube.  Chest tube was placed in ED and drained 1 L of bloody fluid.  Arterial blood gas showed PO2 88 and sats 98% on RA.  Patient was also COVID positive.  Patient had leukocytosis with left shift, tachypneic in the 30s.  Patient was started on Zosyn and Vancomycin.  Patient was tachycardia in the 100s.  Patient expired on 02/23/2022.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Haemorrhage, Leukocytosis, Lymphadenopathy, Metastases to bone
Clinical narrative: Patient brought to Hospital via EMS on 02/17/2022 for SOB.  CT of thorax showed large right effusion, lung metastasis, bone metastasis, supraclavicular and left axillary lymphadenopathy.  Patient had a known hx of Prostate cancer, Parkinson's, dementia, and Peg Tube.  Chest tube was placed in ED and drained 1 L of bloody fluid.  Arterial blood gas showed PO2 88 and sats 98% on RA.  Patient was also COVID positive.  Patient had leukocytosis with left shift, tachypneic in the 30s.  Patient was started on Zosyn and Vancomycin.  Patient was tachycardia in the 100s.  Patient expired on 02/23/2022.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Metastases to lung, PO2 normal, Pleural effusion, SARS-CoV-2 test positive, Shift to the left
Clinical narrative: Patient brought to Hospital via EMS on 02/17/2022 for SOB.  CT of thorax showed large right effusion, lung metastasis, bone metastasis, supraclavicular and left axillary lymphadenopathy.  Patient had a known hx of Prostate cancer, Parkinson's, dementia, and Peg Tube.  Chest tube was placed in ED and drained 1 L of bloody fluid.  Arterial blood gas showed PO2 88 and sats 98% on RA.  Patient was also COVID positive.  Patient had leukocytosis with left shift, tachypneic in the 30s.  Patient was started on Zosyn and Vancomycin.  Patient was tachycardia in the 100s.  Patient expired on 02/23/2022.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Tachycardia, Tachypnoea
Clinical narrative: Patient brought to Hospital via EMS on 02/17/2022 for SOB.  CT of thorax showed large right effusion, lung metastasis, bone metastasis, supraclavicular and left axillary lymphadenopathy.  Patient had a known hx of Prostate cancer, Parkinson's, dementia, and Peg Tube.  Chest tube was placed in ED and drained 1 L of bloody fluid.  Arterial blood gas showed PO2 88 and sats 98% on RA.  Patient was also COVID positive.  Patient had leukocytosis with left shift, tachypneic in the 30s.  Patient was started on Zosyn and Vancomycin.  Patient was tachycardia in the 100s.  Patient expired on 02/23/2022.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Antinuclear antibody negative, Audiogram abnormal, Borrelia test negative, Deafness neurosensory, Deafness unilateral
Clinical narrative: Sudden sensorineural hearing loss Right ear, Prednisone 60 mg, improvement.  Sudden significant hearing loss in right ear, Seen by ENT, no cerumen impaction, given 60mg Prednisone po,, phone audiogram after dosing showed decreased hearing in right ear, repeat phone audiogram 7 hours after dosing showed improvement and clinical symptoms resolved. Bloodwork, formal audiogram, and MRI ordered.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Full blood count, Metabolic function test, Rhesus antigen positive, Sudden hearing loss, Treponema test negative
Clinical narrative: Sudden sensorineural hearing loss Right ear, Prednisone 60 mg, improvement.  Sudden significant hearing loss in right ear, Seen by ENT, no cerumen impaction, given 60mg Prednisone po,, phone audiogram after dosing showed decreased hearing in right ear, repeat phone audiogram 7 hours after dosing showed improvement and clinical symptoms resolved. Bloodwork, formal audiogram, and MRI ordered.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Fully vaccinated patient tested positive for COVID-19.
Age: 62.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Acne, Dermatitis acneiform, Pustule, Scar, Skin swelling
Clinical narrative: 7 days after 1st shot I developed several pimples within an inch of the vaccination site. One had a big white pus head, the other was a larger round shape puffy clear plus looking one, add several smaller tiny pimple rash. Within 2 days they almost completed disappeared.  But I still went to see a doctor who examined me and said most certainly a reaction to the vaccine as I have had no intimate contact with anyone for close to 3 years, no attendance at large gatherings, no massages, nothing involving close contact. Today now 7 days after appearance there is a very small scar where one used to be, and nothing for the others
Age: 62.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Vaccination site reaction
Clinical narrative: 7 days after 1st shot I developed several pimples within an inch of the vaccination site. One had a big white pus head, the other was a larger round shape puffy clear plus looking one, add several smaller tiny pimple rash. Within 2 days they almost completed disappeared.  But I still went to see a doctor who examined me and said most certainly a reaction to the vaccine as I have had no intimate contact with anyone for close to 3 years, no attendance at large gatherings, no massages, nothing involving close contact. Today now 7 days after appearance there is a very small scar where one used to be, and nothing for the others
Age: 4.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Mother identified child as being 5 years old. Vaccine administered 17 days prior to child turning 5.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chest pain, Dyspnoea, Headache, Nausea
Clinical narrative: Breakthrough COVID infection. Patient reports chest pain, shortness of breath, headache, nausea and vomiting starting 08/07/2022. Tested positive 08/08/2022.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Vaccine breakthrough infection, Vomiting
Clinical narrative: Breakthrough COVID infection. Patient reports chest pain, shortness of breath, headache, nausea and vomiting starting 08/07/2022. Tested positive 08/08/2022.
Age: 25.0
Sex: M
Vaccine: TDAP
Symptoms: Expired product administered
Clinical narrative: Expired vaccine was given. Patient did not have any adverse effects.
Age: 89.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient vaccinated against and then tested positive for COVID19
Age: 11.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, Product preparation error
Clinical narrative: Patient given 0.2ml undiluted dose of pediatric vaccine
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Error: Improper storage (ex. temperature/location).
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Fully vaccinated patient tested positive for COVID-19.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Arthralgia, Chills, Confusional state, Dizziness
Clinical narrative: Systemic: Abdominal Pain-Severe, Systemic: Body Aches Generalized-Severe, Systemic: Chills-Severe, Systemic: Confusion-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Exhaustion / Lethargy-Severe, Systemic: Flushed / Sweating-Severe, Systemic: Headache-Medium, Systemic: Joint Pain-Severe, Systemic: Lymph Node Swelling-Medium, Systemic: Nausea-Medium, Systemic: Unable to Sleep-Medium, Additional Details: PATIENT IS IMMUNOCOMPROMISED, HE HAD HIS PRIMARY SERIES(3 DOSES), FIRST BOOSTER AND SECOND BOOSTER(0.25MLS) WHERE HE EXPERIENCED EXTREME SIDE EFFECTS UNLIKE PREVIOUS DOSES. HE HAD FLUID BUILD UP TOO IN HIS EAR WHICH LED TO VERTIGO
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Flushing, Headache, Hyperhidrosis, Immunodeficiency
Clinical narrative: Systemic: Abdominal Pain-Severe, Systemic: Body Aches Generalized-Severe, Systemic: Chills-Severe, Systemic: Confusion-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Exhaustion / Lethargy-Severe, Systemic: Flushed / Sweating-Severe, Systemic: Headache-Medium, Systemic: Joint Pain-Severe, Systemic: Lymph Node Swelling-Medium, Systemic: Nausea-Medium, Systemic: Unable to Sleep-Medium, Additional Details: PATIENT IS IMMUNOCOMPROMISED, HE HAD HIS PRIMARY SERIES(3 DOSES), FIRST BOOSTER AND SECOND BOOSTER(0.25MLS) WHERE HE EXPERIENCED EXTREME SIDE EFFECTS UNLIKE PREVIOUS DOSES. HE HAD FLUID BUILD UP TOO IN HIS EAR WHICH LED TO VERTIGO
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Insomnia, Lethargy, Lymphadenopathy, Nausea, Pain
Clinical narrative: Systemic: Abdominal Pain-Severe, Systemic: Body Aches Generalized-Severe, Systemic: Chills-Severe, Systemic: Confusion-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Exhaustion / Lethargy-Severe, Systemic: Flushed / Sweating-Severe, Systemic: Headache-Medium, Systemic: Joint Pain-Severe, Systemic: Lymph Node Swelling-Medium, Systemic: Nausea-Medium, Systemic: Unable to Sleep-Medium, Additional Details: PATIENT IS IMMUNOCOMPROMISED, HE HAD HIS PRIMARY SERIES(3 DOSES), FIRST BOOSTER AND SECOND BOOSTER(0.25MLS) WHERE HE EXPERIENCED EXTREME SIDE EFFECTS UNLIKE PREVIOUS DOSES. HE HAD FLUID BUILD UP TOO IN HIS EAR WHICH LED TO VERTIGO
Age: 69.0
Sex: F
Vaccine: TDAP
Symptoms: Nausea, Vomiting
Clinical narrative: Nausea and vomiting
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered, Incorrect dose administered, No adverse event
Clinical narrative: This was an immunocompromised patient and he had received 3 doses of the Moderna Covid vaccine 0.5 ml doses.  He was returning for his first booster and should have received 0.25 ml, but I mistakenly chose the box on the protocol stating that he had only received 2 doses prompting me to give this dose as a 0.5 ml dose when it should have been a 0.25 ml dose as his first booster.  It was discovered on 8/4/2022 when he came for his 5th dose, or 2nd booster at 0. 25 ml.  He reported that he had no adverse effects and no issues with his 4th dose of the vaccine and he received his 5th dose without issue.
Age: 60.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient vaccinated against and then tested positive for COVID19
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose increased, COVID-19, Chest discomfort, Cough, Fatigue
Clinical narrative: June 25, I had a dry cough, I believed it to be allergies. Dry cough became worst. I took a COVID-19 test and it came back positive. I felt fatigue and my chest was heavy. The following Monday, I had a telehealth. I was prescribe PAXLOVID. The symptoms left and came back. My blood sugar became high as well.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: June 25, I had a dry cough, I believed it to be allergies. Dry cough became worst. I took a COVID-19 test and it came back positive. I felt fatigue and my chest was heavy. The following Monday, I had a telehealth. I was prescribe PAXLOVID. The symptoms left and came back. My blood sugar became high as well.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Error: Improper Storage (ex. temp./location)-
Age: 2.0
Sex: M
Vaccine: COVID19
Symptoms: Interchange of vaccine products, No adverse event, Wrong product administered
Clinical narrative: Moderna vaccine mistakenly given for second dose; patient had previously received Pfizer.  Patient was planning for full Pfizer series. No symptoms at time of vaccine, no adverse reaction noted. Monitored for 15 minutes after vaccine per protocol. MD aware and discussed with family.
Age: 96.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Medical facility consulted with the health department and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Medical facility is working with the health department on a compliance improvement plan and has been reinstated vaccination privileges.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Error: Improper storage (ex. temperature/location).
Age: 79.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient vaccinated against and then tested positive for COVID19
Age: 10.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, Product preparation error
Clinical narrative: Patient received 0.2ml undiluted dose of vaccine
Age: 49.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dermatitis, Eczema, Rash, Urticaria
Clinical narrative: Developed Eczema/Dermatitis.  I've never had any skin issues and now have repeated breakouts of hives/rashes, especially around groin, armpits, beltline and elbows.  Can be symptomatically controlled with steroid creams, but no long term solution determined.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Error: Improper storage (ex. temperature/location).
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Healthcare consulted with the Dept of Public Health and Environment and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Healthcare is working with the Dept of Public Health and Environment on a compliance improvement plan and has been reinstated vaccination privileges.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient vaccinated against, then tested positive for COVID-19.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Error: Improper storage (ex. temperature/location).
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Error: Improper Storage (ex. temp./location)-
Age: 11.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, Product preparation error
Clinical narrative: Patient received 0.2ml undiluted dose of pediatric vaccine
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Healthcare consulted with the Dept of Public Health and Environment and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Healthcare is working with the Dept of Public Health and Environment on a compliance improvement plan and has been reinstated vaccination privileges.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Error: Improper Storage (ex. temp./location)-
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Error: Improper Storage (ex. temp./location)-
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Condition aggravated, Pain in extremity, Rheumatoid arthritis, Walking aid user
Clinical narrative: Severe rheumatoid arthritis pain in multiple joints. It was so painful that I had to use crutches due to my leg pain. Started taking ALEVE and naproxen for pain.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Chest pain, Formication, Hypoaesthesia, Lip swelling
Clinical narrative: Patient received vaccine at 5:15 pm and around 11:00 pm started a rash on legs and arms. Then had chest pain and pain in abdomen. Then started to have numbing on the face and felt like ants were all over her. She felt a strong pulse in her ears and then got up to look in the mirror and her face, lips and cheeks were swollen. She had red eyes.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Ocular hyperaemia, Rash, Swelling face, Tinnitus
Clinical narrative: Patient received vaccine at 5:15 pm and around 11:00 pm started a rash on legs and arms. Then had chest pain and pain in abdomen. Then started to have numbing on the face and felt like ants were all over her. She felt a strong pulse in her ears and then got up to look in the mirror and her face, lips and cheeks were swollen. She had red eyes.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Death, Pneumonia, SARS-CoV-2 test positive
Clinical narrative: pt had a positive COVID test on 1/14/22 in nursing home where she stays; placed on isolation; ABX; comfort measures only; on O2; pneumonia; pt passed away in the nursing home
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Patient received a vaccine stored beyond 30 days recommended in the refrigerated state. Event reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. It was recommended repeating this dose in question. Patient sent a letter to inform them of the need to repeat the dose in question. We are working on a compliance improvement plan. Reinstated vaccination privileges.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Error: Improper Storage (ex. temp./location)-
Age: 91.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Consulted with the local Dept. of Public Health and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Local Healthcare is working on a compliance improvement plan and has been reinstated vaccination privileges.
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Asymptomatic COVID-19, Cardiac function test, Fall, SARS-CoV-2 test positive, Troponin increased
Clinical narrative: Pt came to hospital for falls at home, tested + for covid but asymptomatic. Troponins elevated cardio work up and patinet discharged to SNF.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received a vaccine stored beyond 30 days recommended in the refrigerated state. Event reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. It was recommended repeating this dose in question. Patient sent a letter to inform them of the need to repeat the dose in question. We are working on a compliance improvement plan. Reinstated vaccination privileges.
Age: 32.0
Sex: F
Vaccine: UNK
Symptoms: Rash, Rash erythematous, Rash pruritic, Skin warm
Clinical narrative: 32-year-old female with a history of diabetes presenting to the emergency department complaining of a red rash noted to the left tricep occurring after receiving her yellow fever vaccine last Thursday.  Rash is described as moderate in nature and is itchy and hot.  Patient has no history of the same.  Patient took 2 Benadryl and hydrocortisone cream with no relief.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Influenza like illness, SARS-CoV-2 test positive
Clinical narrative: Flu-like symptoms 6/22/2022. Tested positive for COVID-19.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Patient received a vaccine stored beyond 30 days recommended in the refrigerated state. Event reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. It was recommended repeating this dose in question. Patient sent a letter to inform them of the need to repeat the dose in question. We are working on a compliance improvement plan. Reinstated vaccination privileges.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Error: Improper storage (ex. temperature/location).
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received a vaccine stored beyond 30 days recommended in the refrigerated state. Event reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. It was  recommended repeating this dose in question. Patient sent a letter to inform them of the need to repeat the dose in question. We are working on a compliance improvement plan. Reinstated vaccination privileges.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Error: Improper storage (ex. temperature/location).
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: Patient received Moderna (NDC:80777-0273-10) booster. Patient only received half of the adult dose.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Medical facility consulted with the health department and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Medical facility is working with the health department on a compliance improvement plan and has been reinstated vaccination privileges.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Atrial fibrillation, COVID-19, COVID-19 pneumonia, Culture positive
Clinical narrative: pt was in the hospital for COVID pneumonia from 1/29 - 2/19/22; 2/20/22 pt had a positive COVID test; pt dc'd to rehab; while in rehab, pt had nausea, vomiting, diarrhea, and hypotension; 2/21/22 taken back to hospital; admitted with sepsis, AHRF; placed on mechanical ventilation; A Fib with rapid ventricular response; vasopressors for shock; respiratory culture grew mold, treated with medication; tube feedings; family decided to withdraw support and pursue comfort measures; pt passed away in the hospital
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Diarrhoea, Feeding tube user, Hypotension, Mechanical ventilation
Clinical narrative: pt was in the hospital for COVID pneumonia from 1/29 - 2/19/22; 2/20/22 pt had a positive COVID test; pt dc'd to rehab; while in rehab, pt had nausea, vomiting, diarrhea, and hypotension; 2/21/22 taken back to hospital; admitted with sepsis, AHRF; placed on mechanical ventilation; A Fib with rapid ventricular response; vasopressors for shock; respiratory culture grew mold, treated with medication; tube feedings; family decided to withdraw support and pursue comfort measures; pt passed away in the hospital
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, SARS-CoV-2 test positive, Sepsis, Shock, Vomiting
Clinical narrative: pt was in the hospital for COVID pneumonia from 1/29 - 2/19/22; 2/20/22 pt had a positive COVID test; pt dc'd to rehab; while in rehab, pt had nausea, vomiting, diarrhea, and hypotension; 2/21/22 taken back to hospital; admitted with sepsis, AHRF; placed on mechanical ventilation; A Fib with rapid ventricular response; vasopressors for shock; respiratory culture grew mold, treated with medication; tube feedings; family decided to withdraw support and pursue comfort measures; pt passed away in the hospital
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Error: Improper storage (ex. temperature/location).
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Atelectasis, Blood test abnormal, Chest pain, Computerised tomogram thorax abnormal, Dizziness
Clinical narrative: Onset over about 5 mins. Trouble breathing, dizziness, sudden headache with possible syncope event with sharp chest pain in left side of body. Went to bed assuming it was a random panic attack, but breathing did not get better and reported to local Urgent Care 8/08/2022. EKG came back normal and was recommended to go to local ER ASAP for further testing to ensure it wasn't a blood clot.   At ER got another EKG, a chest CT, and basic blood work done. EKG came back normal, blood work came back with low MPV. CT came back with no signs of acute pulmonary illness and no embolism, but did come back with "dependent atelectasis in the lungs posteriorly bilaterally". Receiving follow-up with PCP next week.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Electrocardiogram normal, Headache, Mean platelet volume decreased, Panic attack
Clinical narrative: Onset over about 5 mins. Trouble breathing, dizziness, sudden headache with possible syncope event with sharp chest pain in left side of body. Went to bed assuming it was a random panic attack, but breathing did not get better and reported to local Urgent Care 8/08/2022. EKG came back normal and was recommended to go to local ER ASAP for further testing to ensure it wasn't a blood clot.   At ER got another EKG, a chest CT, and basic blood work done. EKG came back normal, blood work came back with low MPV. CT came back with no signs of acute pulmonary illness and no embolism, but did come back with "dependent atelectasis in the lungs posteriorly bilaterally". Receiving follow-up with PCP next week.
Age: 85.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asymptomatic COVID-19, SARS-CoV-2 test positive, Thrombocytopenia, Transfusion
Clinical narrative: Patient was admitted to hospital for thrombocytopenia, treated with transfusions. Upon discharging  pt tested + for covid asymptomatic.
Age: 33.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Guillain-Barre syndrome, Immunoglobulin therapy
Clinical narrative: Guillain Barre, hospitalized, IVIG treatment
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case COVID-19 after fully vaccinated with 2 doses of Moderna.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Patient received Moderna (NDC 80777-0273-10) booster. Patient only received half of the adult dose.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine administered beyond-use-date.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Consulted with the local Dept. of Public Health and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Local Healthcare is working on a compliance improvement plan and has been reinstated vaccination privileges.
Age: 33.0
Sex: M
Vaccine: UNK
Symptoms: Lymph node pain, Lymphadenopathy, Odynophagia, Oropharyngeal pain
Clinical narrative: Sore throat and swollen lymph nodes in neck. Last about a week. Currently symptoms have 90% subsided but lymph nodes on left side of neck are slightly tender to touch. Pain never reached 5/10 when swallowing. No issue with breathing
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Error: Improper storage (ex. temperature/location).
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Healthcare consulted with the Dept of Public Health and Environment and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Healthcare is working with the Dept of Public Health and Environment on a compliance improvement plan and has been reinstated vaccination privileges.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was administrated the beyond use date.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Patient Received Moderna Booster (80777-0273-10) Patient received half dose of the adult booster.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cardio-respiratory arrest, SARS-CoV-2 test positive
Clinical narrative: Patient admitted to LTACH with increasing oxygen requirements.  Tested positive for COVID.  Patient developed cardiopulmonary arrest. ROSC was unable to be obtained.  Patient CTB
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: Patient received Moderna (80777-0273-10) Booster, patient received half of the adult dose.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Error: Improper Storage (ex. temp./location)-
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine administered beyond-use-date.
Age: 14.0
Sex: F
Vaccine: MNQ
Symptoms: Wrong patient received product
Clinical narrative: Patient was here with 16 year old sibling. RN verified the name, birthdate and the wrong child stepped forward to get the vaccine. Rn noticed mistake and notified the provider and Nurse manager immediately. The RN went to tell the family with the Nurse  manager and mom understood that the 14 year old child will need another Menactra dose when she is of age.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: patient received moderna ndc 80777-0273-10 booster, patient received half of the adult dose
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine administered beyond-use-date.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Error: Improper storage (ex. temperature/location).
Age: 53.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Injection site erythema, Injection site mass, Pain
Clinical narrative: Minor but noticeably sore for 2 weeks with a large lump accompanied by redness that appeared at the injection sight about a week after injection.  2.5 weeks in and the redness has gone and the lump has shrunk to about pea sized
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Patient received a vaccine stored beyond 30 days recommended in the refrigerated state. Event reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. It was recommended repeating this dose in question. Patient sent a letter to inform them of the need to repeat the dose in question. We are working on a compliance improvement plan. Reinstated vaccination privileges.
Age: 83.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Cardiac failure congestive, Condition aggravated, Interchange of vaccine products
Clinical narrative: Pt presented with COVID no hypoxia didn't require medication. Pt treated for Chf exacerbation and discharged home once stable.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Six weeks after taking 2nd booster I came down with COVID 19
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: Patient Received Moderna Booster (8077-0273-10) Patient received half of the adult booster dose.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine administered beyond-use-date.
Age: 26.0
Sex: M
Vaccine: HEPA
Symptoms: Expired product administered
Clinical narrative: No adverse event .  Hep A exp. 08/09/2022.  Dose given  on 8/10/2022.  Client called and informed.  Will repeat dose.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Contracted Covid 7/26/22.